Skip to main content
SpringerLink
Log in

A 12-Month Course of Combination Therapy with Interferon-α and Ribavirin in Chronic Hepatitis due to Coinfection with Hepatitis B and C Viruses

  • Correspondence
  • Published:
Clinical Drug Investigation Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Zarski JP, Bohn B, Bastie A, et al. Characteristics of patients with dual infection by hepatitis B and C viruses. J Hepatol 1998; 28(1): 27–33

    Article  PubMed  CAS  Google Scholar 

  2. Liaw YF. Role of hepatitis C virus in dual and triple hepatitis virus infection. Hepatology 1995; 22 (4 Pt 1): 1101–8

    PubMed  CAS  Google Scholar 

  3. Sagnelli E, Coppola N, Scolastico C, et al. Virologic and clinical expressions of reciprocal inhibitory effect of hepatitis B, C, and delta viruses in patients with chronic hepatitis. Hepatology 2000; 32(5): 1106–10

    Article  PubMed  CAS  Google Scholar 

  4. Liaw YF, Chien RN, Lin SM, et al. Response of patients with dual hepatitis B virus and C virus infection to interferon therapy. J Interferon Cytokine Res 1997; 17(8): 449–52

    Article  PubMed  CAS  Google Scholar 

  5. Weltman MD, Brotodihardjo A, Crewe EB, et al. Coinfection with hepatitis B and C or B, C and delta viruses results in severe chronic liver disease and responds poorly to interferon-alpha treatment. J Viral Hepat 1995; 2(1): 39–45

    Article  PubMed  CAS  Google Scholar 

  6. McHutchison JG, Poynard T, Esteban-Mur R, et al. Hepatic HCV RNA before and after treatment with interferon alone or combined with ribavirin. International Hepatitis Interventional Therapy Group. Hepatology 2002; 35(3): 688–93

    Article  PubMed  CAS  Google Scholar 

  7. Villa E, Grottola A, Trande P, et al. Reactivation of hepatitis B virus infection induced by interferon (IFN) in HBsAg-positive, anti HCV-positive patients [letter]. Lancet 1993; 341(8857): 1413

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Hepatology Department of Internal Medicine School of Medicine, Dicle University, 21280, Diyarbakir, Turkey

    Kendal Yalcin & Halil Degertekin

Authors
  1. Kendal Yalcin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Halil Degertekin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kendal Yalcin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yalcin, K., Degertekin, H. A 12-Month Course of Combination Therapy with Interferon-α and Ribavirin in Chronic Hepatitis due to Coinfection with Hepatitis B and C Viruses. Clin. Drug Investig. 22, 797–798 (2002). https://doi.org/10.2165/00044011-200222110-00009

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00044011-200222110-00009

Keywords

Search

Navigation